|
|
|
1 |
3SBio Inc. Announces Extraordinary General Meeting of Shareholders
|
02-May-2013 |
|
2 |
3SBio Inc. Announces Extraordinary General Meeting of Shareholders
|
02-May-2013 |
|
3 |
3SBio Inc. Files Annual Report on Form 20-F for Fiscal Year 2012
|
01-May-2013 |
|
4 |
3SBio Inc. Adjourns Extraordinary General Meeting of Shareholders
|
25-Apr-2013 |
|
5 |
3SBio Inc. Enters Into Amendment to Merger Agreement For "Going Private" Transaction
|
24-Apr-2013 |
|
6 |
3SBio Inc. Announces Receipt of Amended "Going Private" Proposal at $16.70 Per ADS and Intent to Adjourn Extraordinary General Meeting of Shareholders
|
23-Apr-2013 |
|
7 |
3SBio Inc. Announces Extraordinary General Meeting of Shareholders
|
24-Mar-2013 |
|
8 |
3SBio Inc. Announces Unaudited Fourth Quarter and Full Year 2012 Results
|
18-Mar-2013 |
|
9 |
3SBio Inc. Schedules Unaudited Fourth Quarter and Full Year 2012 Results
|
03-Mar-2013 |
|
10 |
3SBio Inc. Enters Into Merger Agreement For "Going Private" Transaction
|
08-Feb-2013 |
|
11 |
3SBio Inc. Announces Unaudited Third Quarter 2012 Results
|
11-Nov-2012 |
|
12 |
3SBio Inc. Announces Results Of 2012 Annual General Meeting
|
13-Oct-2012 |
|
13 |
3SBio Inc. Schedules Unaudited Third Quarter 2012 Results
|
09-Oct-2012 |
|
14 |
3SBio Independent Committee Selects Financial Advisor in Connection with Going Private Proposal
|
28-Sep-2012 |
|
15 |
3SBio Independent Committee Selects Legal Counsel in connection with Going Private Proposal
|
17-Sep-2012 |
|
16 |
3SBio Inc. Announces Receipt of "Going Private" Proposal at $15 Per ADS
|
12-Sep-2012 |
|
17 |
3SBio Inc. to Hold 2012 Annual General Meeting on October 10, 2012
|
10-Sep-2012 |
|
18 |
3SBio Inc. Announces Unaudited Second Quarter and First Half 2012
|
15-Aug-2012 |
|
19 |
3SBio Inc. Announces Changes to Its Board of Directors
|
09-Aug-2012 |
|
20 |
3SBio Inc. Schedules Unaudited Second Quarter 2012 Results
|
17-Jul-2012 |
|
21 |
3SBio Obtains SFDA Approval to Join Global Phase III Trial for Voclosporin
|
28-Jun-2012 |
|
22 |
3SBio Inc. To Present at the BofAML HK / China Healthcare Corporate Day
|
06-Jun-2012 |
|
23 |
3SBio Inc. To Present at the DB Access Asia Conference 2012
|
27-May-2012 |
|
24 |
3SBio Inc. Announces Unaudited First Quarter 2012 Results
|
14-May-2012 |
|
25 |
3SBio Inc. Files Annual Report on Form 20-F for Fiscal Year 2011
|
01-May-2012 |
|
26 |
3SBio Inc. Schedules Unaudited First Quarter 2012 Results
|
24-Apr-2012 |
|
27 |
3SBio Inc. Announces Changes to its Board of Directors
|
22-Mar-2012 |
|
28 |
3SBio Inc. Announces Unaudited Fourth Quarter and Full Year 2011 Results
|
09-Mar-2012 |
|
29 |
3SBio and DaVita Collaborate on Dialysis Clinics in Northeastern China
|
09-Mar-2012 |
|
30 |
3SBio Inc. to Present at the Oppenheimer & Co. 6th Annual China Dragon Conference
|
07-Feb-2012 |
|
31 |
3SBio Inc. Schedules Unaudited Fourth Quarter and Full Year 2011 Results
|
04-Feb-2012 |
|
32 |
3SBio Inc. to Present at the UBS Greater China Conference 2012
|
10-Jan-2012 |
|
33 |
3SBio Inc. to Present at 30th Annual J.P. Morgan Healthcare Conference
|
05-Jan-2012 |
|
34 |
3SBio Announces Unaudited Third Quarter 2011 Results
|
11-Nov-2011 |
|
35 |
3SBio Inc. Schedules Unaudited Third Quarter 2011 Results
|
20-Oct-2011 |
|
36 |
3SBio Inc. to Hold 2011 Annual General Meeting on September 20, 2011
|
20-Aug-2011 |
|
37 |
3SBio Inc. Announces Unaudited Second Quarter and First Half 2011 Results
|
16-Aug-2011 |
|
38 |
3SBio Inc. Schedules Unaudited Second Quarter 2011 Results
|
22-Jul-2011 |
|
39 |
3SBio Inc. Announces SFDA Approval of High-Dose EPIAO
|
12-Jul-2011 |
|
40 |
3SBio Inc. Announces Unaudited First Quarter 2011 Results
|
12-May-2011 |
|
41 |
3SBio Inc. Schedules Unaudited First Quarter 2011 Results
|
04-May-2011 |
|
42 |
3SBio Inc. Announces Unaudited Fourth Quarter and Full Year 2010 Results
|
16-Mar-2011 |
|
43 |
3SBio Inc. Schedules Unaudited Fourth Quarter and Fiscal Year 2010 Results
|
19-Feb-2011 |
|
44 |
3SBio Inc. Submits Application for NuPIAO Phase I Clinical Trial
|
12-Feb-2011 |
|
45 |
3SBio Inc. Receives SFDA Approval for TPIAO Label Extension for the Treatment of ITP
|
25-Jan-2011 |
|
46 |
3SBio Inc. Acquires Worldwide Rights to Pegsiticase From EnzymeRx
|
29-Nov-2010 |
|
47 |
3SBio Inc. Announces Results of Annual General Meeting
|
24-Nov-2010 |
|
48 |
3SBio Announces Partial Conversion of Isotechnika Debenture
|
19-Nov-2010 |
|
49 |
3SBio Inc. Announces Unaudited Third Quarter Results
|
16-Nov-2010 |
|
50 |
3SBio Inc. Schedules Third Quarter 2010 Unaudited Financial Results
|
18-Oct-2010 |
|
51 |
3SBio Announces Partial Conversion of Isotechnika Debenture
|
14-Sep-2010 |
|
52 |
3SBio Announces Investor Conference Schedule
|
07-Sep-2010 |
|
53 |
3SBio and Isotechnika Pharma Announce Strategic Partnership to Develop and Commercialize Voclosporin in China
|
24-Aug-2010 |
|
54 |
3SBio Inc. Announces Unaudited Second Quarter Results
|
18-Aug-2010 |
|
55 |
3SBio Inc. Schedules Second Quarter 2010 Unaudited Financial Results
|
05-Aug-2010 |
|
56 |
3SBio Inc. Announces Filing of Form 20-F With SEC
|
28-Jun-2010 |
|
57 |
3SBio Inc. Announces Unaudited First Quarter 2010 Results
|
16-May-2010 |
|
58 |
3SBio Inc. To Report 2010 First Quarter Unaudited Financial Results on May 16, 2010
|
11-May-2010 |
|
59 |
3SBio Announces Changes to its Board of Directors
|
10-Mar-2010 |
|
60 |
3SBio Inc. Announces Unaudited Fourth Quarter and Full Year 2009 Results
|
12-Feb-2010 |
|
61 |
3SBio and Ascentage Pharma Form Strategic Alliance to Research, Develop and Commercialize Cancer Therapeutics
|
12-Feb-2010 |
|
62 |
3SBio and Panacor Bioscience Enter Collaboration and License Agreement to Develop and Commercialize Nephoxil(R) for Hyperphosphatemia
|
08-Feb-2010 |
|
63 |
3SBio Inc. to Report 2009 Fourth Quarter and Full Year Results on February 11, 2010
|
26-Jan-2010 |
|
64 |
3SBio Inc. Applies for SFDA Registrational Trial for Feraheme(TM)
|
08-Jan-2010 |
|
65 |
3SBio Inc. to Hold 2010 Annual General Meeting on October 29, 2010
|
27-Nov-2009 |
|
66 |
3SBio Inc. Announces Unaudited Third Quarter 2009 Results
|
13-Nov-2009 |
|
67 |
3SBio Inc. to Report 2009 Third Quarter Earnings on November 12, 2009
|
28-Oct-2009 |
|
68 |
3SBio Inc. Announces Results of Annual General Meeting
|
20-Oct-2009 |
|
69 |
3SBio Inc. to Hold 2009 Annual General Meeting on October 12, 2009
|
07-Sep-2009 |
|
70 |
3SBio Inc. Announces Unaudited Second Quarter 2009 Results
|
12-Aug-2009 |
|
71 |
3SBio Inc. to Report 2009 Second Quarter Earnings on August 11, 2009
|
23-Jul-2009 |
|
72 |
3SBio Inc. Announces Unaudited First Quarter 2009 Results
|
20-May-2009 |
|
73 |
3SBio Inc. Announces Appointment of Ernst & Young Hua Ming as Independent Auditor
|
05-May-2009 |
|
74 |
3SBio Inc. to Report 2009 First Quarter Earnings on May 19, 2009
|
04-May-2009 |
|
75 |
3SBio Inc. Announces Unaudited Fourth Quarter and Fiscal Year 2008 Results
|
12-Mar-2009 |
|
76 |
3SBio Inc. Receives Official Recognition as a ‘High-Tech Enterprise’
|
05-Mar-2009 |
|
77 |
3SBio Inc. to Report 2008 Fourth Quarter and Full Year Earnings on March 11, 2009
|
25-Feb-2009 |
|
78 |
3SBio Inc. Appoints Mr. Bo Tan as Chief Financial Officer
|
09-Feb-2009 |
|
79 |
3SBio Inc. Files for SFDA Approval for TPIAO Label Extension for the Treatment of ITP
|
20-Jan-2009 |
|
80 |
3SBio Inc. to Present at the Piper Jaffray 20th Annual Health Care Conference
|
25-Nov-2008 |
|
81 |
3SBio Inc. Announces Preliminary Third Quarter 2008 Results
|
11-Nov-2008 |
|
82 |
3SBio Inc. Files for SFDA Approval of NuLeusin
|
10-Nov-2008 |
|
83 |
3SBio Inc. Announces Preliminary Third Quarter 2008 Results
|
01-Nov-2008 |
|
84 |
3SBio Inc. Schedules 2008 Third Quarter Earnings Release on Monday, November 10, 2008
|
16-Oct-2008 |
|
85 |
3SBio Inc. Files for SFDA Approval of High-dose (36,000 IU) EPIAO
|
25-Sep-2008 |
|
86 |
3SBio Inc. to Present at the UBS Global Life Sciences Conference
|
17-Sep-2008 |
|
87 |
3SBio Inc. Announces Results of Annual General Meeting
|
15-Sep-2008 |
|
88 |
3SBio Inc. to Present at the Morgan Stanley Global Healthcare Unplugged Conference
|
26-Aug-2008 |
|
89 |
3SBio Inc. to Hold Annual General Meeting
|
21-Aug-2008 |
|
90 |
3SBio Inc. Announces Second Quarter 2008 Results
|
13-Aug-2008 |
|
91 |
3SBio Inc. Schedules 2008 Second Quarter Earnings Release On Tuesday, August 12, 2008
|
30-Jul-2008 |
|
92 |
3SBio Inc. Announces Filing of Annual Report on Form 20-F
|
01-Jul-2008 |
|
93 |
3SBio Inc. to Present at the Goldman Sachs Twenty-Ninth Annual Global Healthcare Conference
|
28-May-2008 |
|
94 |
AMAG Pharmaceuticals, Inc. and 3SBio, Inc. Announce Strategic Partnership to Develop and Commercialize Ferumoxytol in China
|
28-May-2008 |
|
95 |
3SBio Inc. to Present at The Oppenheimer 2nd Annual China Dragon Call Conference
|
19-May-2008 |
|
96 |
3SBio Inc. Announces First Quarter 2008 Results
|
15-May-2008 |
|
97 |
3SBio Inc. Schedules 2008 First Quarter Earnings Release on Wednesday, May 14, 2008
|
29-Apr-2008 |
|
98 |
3SBio Inc. Announces Promotion of David Chen as Chief Operating Officer
|
20-Mar-2008 |
|
99 |
3SBio Inc. Approves Share Repurchase Program
|
20-Mar-2008 |
|
100 |
3SBio Inc. Announces Unaudited Fourth Quarter and Fiscal Year 2007 Results
|
21-Feb-2008 |
|
101 |
3SBio Inc. Announces Change to the Board of Directors
|
20-Feb-2008 |
|
102 |
3SBio Inc. Schedules 2007 Fourth Quarter and Full Year Earnings Release on Wednesday, February 20, 2008
|
12-Feb-2008 |
|
103 |
3SBio Inc. to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
|
30-Jan-2008 |
|
104 |
3SBio Inc. Announces Appointment of Kevin Sow Peng Teo as Chief Financial Officer
|
28-Jan-2008 |
|
105 |
3SBio Inc. To Present at the 19th Annual Piper Jaffray Health Care Conference
|
20-Nov-2007 |
|
106 |
3SBio Inc. Announces Third Quarter 2007 Results
|
13-Nov-2007 |
|
107 |
3SBio Inc. Schedules 2007 Third Quarter Earnings Release On Tuesday, November 13, 2007
|
31-Oct-2007 |
|
108 |
3SBio Inc. To Present At The CIBC World Markets 18th Annual Healthcare Conference
|
29-Oct-2007 |
|
109 |
3SBio Inc. to Hold Annual General Meeting
|
18-Sep-2007 |
|
110 |
3SBio Inc. to Present at the UBS Global Life Sciences Conference
|
17-Sep-2007 |
|
111 |
3SBio Inc. Announces Second Quarter 2007 Results
|
09-Aug-2007 |
|
112 |
3SBio Inc. Schedules 2007 Second Quarter Earnings Release on Wednesday, August 8, 2007
|
02-Aug-2007 |
|
113 |
3SBio Inc. Announces Filing of Annual Report on Form 20-F
|
02-Jul-2007 |
|
114 |
3SBio Inc. Schedules 2007 First Quarter Earnings Release on Tuesday, May 1, 2007
|
27-May-2007 |
|
115 |
3SBio Inc. to Present at the CIBC World Markets China Dragon Call Conference
|
26-May-2007 |
|
116 |
3SBio Inc. to Present at the UBS Global Generic and Specialty Pharmaceuticals Conference and the Merrill Lynch Pan Asia Rising Stars Conference
|
07-May-2007 |
|
117 |
3SBio Inc. Announces First Quarter 2007 Results
|
02-May-2007 |
|
118 |
3SBio Inc. to Present at the 2007 CIBC World Markets Annual Biotechnology & Specialty Pharmaceutical Conference
|
11-Apr-2007 |
|
119 |
3SBio Inc. Announces Fourth Quarter And Fiscal Year 2006 Results
|
03-Apr-2007 |
|
120 |
3SBio Inc. Schedules Fourth Quarter and Fiscal Year 2006 Earnings Release on Monday, April 2, 2007
|
22-Mar-2007 |
| |
|
|